Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK543166PMID: 31260232
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 389574-19-0
Drug Levels and Effects
Summary of Use during Lactation
No published information is available on the use of prasugrel during breastfeeding. Until more data become available, prasugrel should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant. If it is used by a nursing mother, monitor the infant for bruising and bleeding.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Prasugrel
CAS Registry Number
389574-19-0
Drug Class
- Breastfeeding
- Platelet Aggregation Inhibitors
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Clopidogrel.[Drugs and Lactation Database (...]Review Clopidogrel.. Drugs and Lactation Database (LactMed®). 2006
- The biotransformation of prasugrel, a new thienopyridine prodrug, by the human carboxylesterases 1 and 2.[Drug Metab Dispos. 2008]The biotransformation of prasugrel, a new thienopyridine prodrug, by the human carboxylesterases 1 and 2.Williams ET, Jones KO, Ponsler GD, Lowery SM, Perkins EJ, Wrighton SA, Ruterbories KJ, Kazui M, Farid NA. Drug Metab Dispos. 2008 Jul; 36(7):1227-32. Epub 2008 Mar 27.
- The intestine as an important contributor to prasugrel active metabolite formation in vivo.[Drug Metab Dispos. 2011]The intestine as an important contributor to prasugrel active metabolite formation in vivo.Hagihara K, Kazui M, Ikenaga H, Nanba T, Fusegawa K, Izumi T, Ikeda T, Kurihara A. Drug Metab Dispos. 2011 Apr; 39(4):565-70. Epub 2010 Dec 28.
- Review Ticagrelor.[Drugs and Lactation Database (...]Review Ticagrelor.. Drugs and Lactation Database (LactMed®). 2006
- Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450.[Drug Metab Dispos. 2006]Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450.Rehmel JL, Eckstein JA, Farid NA, Heim JB, Kasper SC, Kurihara A, Wrighton SA, Ring BJ. Drug Metab Dispos. 2006 Apr; 34(4):600-7. Epub 2006 Jan 13.
- Prasugrel - Drugs and Lactation Database (LactMed®)Prasugrel - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...